Evidence map›Paper›PMID 33768219›Full record

ArticleBlood and genomics2020

Coronavirus disease 2019 (COVID-19): diagnosis and prognosis.

Xueying Wang, Yang Zhou, Linlin Liu, Jinmin Ma, Honglong Wu, Lijian Zhao, Weijun Chen, Shengwen Calvin Li, Qian Ran, Zhongjun Li

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Blood and genomics, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed.

  1. Article
  2. Review
  3. Article
  4. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors.

Xueying WangLab Medicine Center, Lab of Radiation Biology, State Key Laboratory of Trauma, Burn and Combined Injury, The Second Affiliated Hospital, Army Medical University, Chongqing 400037, China.
Yang ZhouBGI PathoGenesis Pharmaceutical Technology, BGI-Shenzhen, Shenzhen 518083, China.
Linlin LiuLab Medicine Center, Lab of Radiation Biology, State Key Laboratory of Trauma, Burn and Combined Injury, The Second Affiliated Hospital, Army Medical University, Chongqing 400037, China.
Jinmin MaBGI PathoGenesis Pharmaceutical Technology, BGI-Shenzhen, Shenzhen 518083, China.
Honglong WuBGI PathoGenesis Pharmaceutical Technology, BGI-Shenzhen, Shenzhen 518083, China.
Lijian ZhaoBGI PathoGenesis Pharmaceutical Technology, BGI-Shenzhen, Shenzhen 518083, China.
Weijun ChenBGI PathoGenesis Pharmaceutical Technology, BGI-Shenzhen, Shenzhen 518083, China.
Shengwen Calvin LiCHOC Children's Hospital Research Institute, University of California, Irvine, 1201 West La Veta Ave, Orange, CA 92868, USA.
Qian RanLab Medicine Center, Lab of Radiation Biology, State Key Laboratory of Trauma, Burn and Combined Injury, The Second Affiliated Hospital, Army Medical University, Chongqing 400037, China.
Zhongjun LiLab Medicine Center, Lab of Radiation Biology, State Key Laboratory of Trauma, Burn and Combined Injury, The Second Affiliated Hospital, Army Medical University, Chongqing 400037, China.

Funding

IDENTIFICATION OF CAVEOLIN-INTERACTING MOLECULESF32CA071326 · NCI · WHITEHEAD INSTITUTE FOR BIOMEDICAL RES · PI LI, SHENGWEN CALVIN · 1996 to 1998
–
NCI NIH HHS F32 CA071326
6 · The paper itself

Abstract

Coronavirus disease 2019 (COVID-19) has become a global pandemic with a high rate of transmission. Currently, there is a lack of vaccines and specific drugs for this newly-emerged virus. Timely diagnosis and treatment, as well as isolation of patients and virus carriers, contribute to the effective prevention and control of this epidemic. This review focuses on early stage COVID-19 diagnosis methods and strategies, highlighting the guiding role of laboratory indicators on treatment strategy formulation, and prognosis assessments.

Indexed as

COVID-19etiological examinationlaboratory examinationnucleic acid testSARS-CoV-2

Identifiers

PMID33768219
PMCPMC7990318

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.